Last reviewed · How we verify
Spironolactone 200Mg
At a glance
| Generic name | Spironolactone 200Mg |
|---|---|
| Also known as | Aldactone |
| Sponsor | Medical University of South Carolina |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women (PHASE1)
- RELieving Increasing oEdema Due to Heart Failure (PHASE4)
- Spironolactone for Hidradenitis Suppurativa (PHASE4)
- Spironolactone for the Treatment of Melasma (PHASE1)
- Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension (PHASE3)
- The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide. (PHASE2)
- The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia (PHASE4)
- Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spironolactone 200Mg CI brief — competitive landscape report
- Spironolactone 200Mg updates RSS · CI watch RSS
- Medical University of South Carolina portfolio CI